Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis

C. Salliot; A. Finckh; W. Katchamart; Y. Lu; Y. Sun; C. Bombardier; E. Keystone

doi:10.1136/ard.2010.132134

Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis

Annals of the Rheumatic Diseases ◽

10.1136/ard.2010.132134 ◽

2010 ◽

Vol 70 (2) ◽

pp. 266-271 ◽

Cited By ~ 91

Author(s):

C. Salliot ◽

A. Finckh ◽

W. Katchamart ◽

Y. Lu ◽

Y. Sun ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Meta Analysis ◽

Inadequate Response ◽

Disease Modifying Antirheumatic Drugs ◽

Antirheumatic Drugs ◽

Disease Modifying ◽

Indirect Comparisons ◽

Necrosis Factor

Download Full-text

Correction: Ixekizumab is efficacious when used alone or when added to conventional synthetic disease-modifying antirheumatic drugs (cDMARDs) in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor inhibitors

RMD Open ◽

10.1136/rmdopen-2018-000692corr1 ◽

2019 ◽

Vol 5 (1) ◽

pp. e000692corr1

Keyword(s):

Psoriatic Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Inadequate Response ◽

Disease Modifying Antirheumatic Drugs ◽

Antirheumatic Drugs ◽

Tumour Necrosis Factor Inhibitors ◽

Disease Modifying ◽

Necrosis Factor

Download Full-text

The persistence of golimumab compared to other tumour necrosis factor-α inhibitors in daily clinical practice for the treatment of rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: observations from the Slovenian nation-wide longitudinal registry of patients treated with biologic disease-modifying antirheumatic drugs—BioRx.si

Clinical Rheumatology ◽

10.1007/s10067-018-4324-7 ◽

2018 ◽

Vol 38 (2) ◽

pp. 297-305 ◽

Cited By ~ 7

Author(s):

Žiga Rotar ◽

◽

Matija Tomšič ◽

Sonja Praprotnik

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Practice ◽

Psoriatic Arthritis ◽

Tumour Necrosis ◽

Tumour Necrosis Factor Α ◽

Disease Modifying Antirheumatic Drugs ◽

Antirheumatic Drugs ◽

Disease Modifying ◽

Factor Α ◽

Necrosis Factor

Download Full-text

SAT0115 Tofacitinib Versus Biologic Treatments in Patients with Active Rheumatoid Arthritis Who have had an Inadequate Response to Tumour Necrosis Factor Inhibitors - A Network Meta-Analysis

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-eular.1841 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A619.3-A620 ◽

Cited By ~ 1

Author(s):

M. C. Vieira ◽

G. Wallenstein ◽

J. Bradley ◽

D. Gruben ◽

T. Koncz ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Inadequate Response ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text

AB0552 Relative efficacy and tolerability of intravenous and subcutaneous abatacept compared with tumor necrosis factor inhibitors in rheumatoid arthritis patients with an inadequate response to conventional disease-modifying antirheumatic drugs

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2012-eular.552 ◽

2013 ◽

Vol 71 (Suppl 3) ◽

pp. 670.1-670

Author(s):

M. Hochberg ◽

S. Berry ◽

K. Broglio ◽

A. Nadkarni ◽

L. Rosenblatt ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Inadequate Response ◽

Tumor Necrosis Factor Inhibitors ◽

Relative Efficacy ◽

Disease Modifying Antirheumatic Drugs ◽

Antirheumatic Drugs ◽

Disease Modifying ◽

Necrosis Factor

Download Full-text

Trajectory of radiographic change over a decade: the effect of transition from conventional synthetic disease-modifying antirheumatic drugs to anti-tumour necrosis factor in patients with psoriatic arthritis

Rheumatology ◽

10.1093/rheumatology/key297 ◽

2018 ◽

Vol 58 (2) ◽

pp. 269-273 ◽

Cited By ~ 5

Author(s):

Andrew Allard ◽

Anna Antony ◽

Gavin Shaddick ◽

Deepak R Jadon ◽

Charlotte Cavill ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Disease Modifying Antirheumatic Drugs ◽

Antirheumatic Drugs ◽

Radiographic Change ◽

Disease Modifying ◽

Necrosis Factor

Download Full-text

PMS5 Comparative Efficacy of Filgotinib Versus Alternative Treatments for Rheumatoid Arthritis in Patients with an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: A Systematic Review and Network Meta-Analysis

Value in Health ◽

10.1016/j.jval.2020.08.1136 ◽

2020 ◽

Vol 23 ◽

pp. S592-S593

Author(s):

I. Jacob ◽

L. Beresford ◽

K. Butler ◽

B. McNamara ◽

J. Dennis ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Meta Analysis ◽

Inadequate Response ◽

Comparative Efficacy ◽

Alternative Treatments ◽

Disease Modifying Antirheumatic Drugs ◽

Antirheumatic Drugs ◽

Disease Modifying

Download Full-text

Faculty Opinions recommendation of The efficacy of inhibiting tumour necrosis factor alpha and interleukin 1 in patients with rheumatoid arthritis: a meta-analysis and adjusted indirect comparisons.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13284967.14644067 ◽

2011 ◽

Author(s):

Claudia Sommer

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Meta Analysis ◽

Interleukin 1 ◽

Tumour Necrosis Factor Alpha ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Indirect Comparisons ◽

Necrosis Factor

Download Full-text

Sarilumab and Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis and Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors

Arthritis & Rheumatology ◽

10.1002/art.39944 ◽

2017 ◽

Vol 69 (2) ◽

pp. 277-290 ◽

Cited By ~ 71

Author(s):

Roy Fleischmann ◽

Janet van Adelsberg ◽

Yong Lin ◽

Geraldo da Rocha Castelar-Pinheiro ◽

Jan Brzezicki ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Active Rheumatoid Arthritis ◽

Inadequate Response ◽

Tumor Necrosis Factor Inhibitors ◽

Disease Modifying Antirheumatic Drugs ◽

Antirheumatic Drugs ◽

Disease Modifying ◽

Necrosis Factor

Download Full-text

Efficacy and safety of tofacitinib for active rheumatoid arthritis with an inadequate response to methotrexate or disease-modifying antirheumatic drugs: a meta-analysis of randomized controlled trials

The Korean Journal of Internal Medicine ◽

10.3904/kjim.2014.29.5.656 ◽

2014 ◽

Vol 29 (5) ◽

pp. 656 ◽

Cited By ~ 21

Author(s):

Gwan Gyu Song ◽

Sang-Cheol Bae ◽

Young Ho Lee

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Controlled Trials ◽

Inadequate Response ◽

Efficacy And Safety ◽

Disease Modifying Antirheumatic Drugs ◽

Antirheumatic Drugs ◽

Randomized Controlled ◽

Disease Modifying

Download Full-text

The efficacy of inhibiting tumour necrosis factor and interleukin 1 in patients with rheumatoid arthritis: a meta-analysis and adjusted indirect comparisons

Rheumatology ◽

10.1093/rheumatology/kem072 ◽

2007 ◽

Vol 46 (7) ◽

pp. 1140-1147 ◽

Cited By ~ 65

Author(s):

R. Nixon ◽

N. Bansback ◽

A. Brennan

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Meta Analysis ◽

Interleukin 1 ◽

Indirect Comparisons ◽

Necrosis Factor

Download Full-text